Sangamo Biosciences Inc. (SGMO)

Last Three Months

19-Jan-24 -- 18-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

40

0

5

+1

0

+2

0

+3

Two Year Chart

19-Apr-22 -- 18-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Feb-24 5:13 PM View:	25-Feb-24 Payment of Exercise ($3.90K)	Willoughby Scott B. SVP, Gen. Counsel & Secretary		Sangamo Biosciences Inc. - SGMO	535% 131.76K to 836.43K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:11 PM View:	25-Feb-24 Payment of Exercise ($27.30K)	MacRae Sandy President, CEO and Director Director		Sangamo Biosciences Inc. - SGMO	331% 592.48K to 2.55M	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:12 PM View:	25-Feb-24 Payment of Exercise ($3.90K)	Duraibabu Prathyusha SVP, Chief Financial Officer		Sangamo Biosciences Inc. - SGMO	537% 131.0K to 834.58K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:13 PM View:	25-Feb-24 Payment of Exercise ($5.66K)	Dubois-Stringfellow Nathalie SVP-Chief Development Officer		Sangamo Biosciences Inc. - SGMO	487% 144.17K to 846.19K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:14 PM View:	25-Feb-24 Payment of Exercise ($2.78K)	Pooler Amy VP, Head of Research		Sangamo Biosciences Inc. - SGMO	285% 50.98K to 196.31K	0	0	--	--	Show Txns Hide Txns